Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation

This European-headquartered Company employs more than 20,000 people and operates in over 100 countries, with more than ten globally dispersed manufacturing sites. The Company provides supplies for companies working throughout the Life Sciences, including in research, clinical trials, manufacturing, diagnosis, and treatment. It also develops, produces, and provides innovative healthcare services and solutions to diagnose and treat a range of diseases, including rare conditions, for millions of patients around the world.   Read More

Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation

Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation

Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation

Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation

Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation